Late Breaking Abstract - Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease - COPD-ST2OP: a phase IIa, placebo-controlled trial

Autor:	Catherine John, Sarah Glover, Michael C Steiner, Kate Hadley, Koirobi Haldar, Claudia Micieli, A Yousuf, Joanne Finch, Christopher E. Brightling, Dorothy Cheung, S B Mohammed, Liesl Carr, Rachel Hobson, Sarah Parker, Cassandra Brookes, David F. Choy, Vijay Mistry, Richard Russell, Petr Novotny, Niamh Quann, Wadah Ibrahim, Neil J. Greening, Mohammadali Yavari Ramsheh, Michele A. Grimbaldeston, Adam K. A. Wright
Rok vydání:	2021
Předmět:	medicine.medical_specialty COPD business.industry Internal medicine medicine Placebo-controlled study Pulmonary disease medicine.disease business Gastroenterology
Zdroj:	Airway pharmacology and treatment.
DOI:	10.1183/13993003.congress-2021.rct206
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c1a03b7f6b09c543411cf14dad9d67a7 https://doi.org/10.1183/13993003.congress-2021.rct206 Zobrazit plný text záznamu